United States Active Pharmaceutical Ingredient Market Assessment, By Synthesis [Biotech, Synthetic], By Potency [Traditional API, HPAPI], By Manufacturer [Captive APIs, Merchant APIs], By Type [Generic APIs, Innovative APIs], By Drug [Prescription Drugs, Over-the-counter Drugs], By Usage [Clinical, Research], By Application [Cardiovascular Diseases, Oncology, Neurology, Orthopedic, Diabetes, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Others], By Region, Opportunities and Forecast, 2017-2031F

United States active pharmaceutical ingredient market size was valued at USD 33.19 billion in 2023, and is expected to reach USD 60.89 billion in 2031, with a CAGR of 7.88% for the forecast period between 2024 and 2031.

United States active pharmaceutical ingredient market Size Report, 2031

United States Active Pharmaceutical Ingredient Market Assessment, Opportunities and Forecast, 2017-2031F

The United States active pharmaceutical ingredient market size was valued at USD 33.19 billion in 2023, which is expected to reach USD 60.89 billion in 2031, with a CAGR of 7.88% for the forecast period between 2024 and 2031F.

FAQs

Industry Reports

Blogs

Case Studies

Industry News

Press Release

Infographics